198 related articles for article (PubMed ID: 35712073)
1. Poroptosis: A form of cell death depending on plasma membrane nanopores formation.
Li H; Wang Z; Fang X; Zeng W; Yang Y; Jin L; Wei X; Qin Y; Wang C; Liang W
iScience; 2022 Jun; 25(6):104481. PubMed ID: 35712073
[TBL] [Abstract][Full Text] [Related]
2. Engineered exosomes as an in situ DC-primed vaccine to boost antitumor immunity in breast cancer.
Huang L; Rong Y; Tang X; Yi K; Qi P; Hou J; Liu W; He Y; Gao X; Yuan C; Wang F
Mol Cancer; 2022 Feb; 21(1):45. PubMed ID: 35148751
[TBL] [Abstract][Full Text] [Related]
3. Nanomicelle protects the immune activation effects of Paclitaxel and sensitizes tumors to anti-PD-1 Immunotherapy.
Yang Q; Shi G; Chen X; Lin Y; Cheng L; Jiang Q; Yan X; Jiang M; Li Y; Zhang H; Wang H; Wang Y; Wang Q; Zhang Y; Liu Y; Su X; Dai L; Tang M; Li J; Zhang L; Qian Z; Yu D; Deng H
Theranostics; 2020; 10(18):8382-8399. PubMed ID: 32724476
[TBL] [Abstract][Full Text] [Related]
4. ZnO-based multifunctional nanocomposites to inhibit progression and metastasis of melanoma by eliciting antitumor immunity via immunogenic cell death.
Zhang Y; Guo C; Liu L; Xu J; Jiang H; Li D; Lan J; Li J; Yang J; Tu Q; Sun X; Alamgir M; Chen X; Shen G; Zhu J; Tao J
Theranostics; 2020; 10(24):11197-11214. PubMed ID: 33042278
[No Abstract] [Full Text] [Related]
5. Dynamical Boolean Modeling of Immunogenic Cell Death.
Checcoli A; Pol JG; Naldi A; Noel V; Barillot E; Kroemer G; Thieffry D; Calzone L; Stoll G
Front Physiol; 2020; 11():590479. PubMed ID: 33281620
[TBL] [Abstract][Full Text] [Related]
6. The Host-Defense-Peptide-Mimicking Synthetic Polypeptides Effectively Enhance Antitumor Immunity through Promoting Immunogenic Tumor Cell Death.
Wang Y; Shen W; Liu S; Zhu G; Meng X; Mao K; Wang J; Yang YG; Xiao C; Sun T
Macromol Biosci; 2021 Sep; 21(9):e2100171. PubMed ID: 34169661
[TBL] [Abstract][Full Text] [Related]
7. Sequential receptor-mediated mixed-charge nanomedicine to target pancreatic cancer, inducing immunogenic cell death and reshaping the tumor microenvironment.
Shen J; Sun C; Wang Z; Chu Z; Liu C; Xu X; Xia M; Zhao M; Wang C
Int J Pharm; 2021 May; 601():120553. PubMed ID: 33794325
[TBL] [Abstract][Full Text] [Related]
8. Cell death induced by cytotoxic CD8
Jaime-Sanchez P; Uranga-Murillo I; Aguilo N; Khouili SC; Arias MA; Sancho D; Pardo J
J Immunother Cancer; 2020 Apr; 8(1):. PubMed ID: 32241808
[TBL] [Abstract][Full Text] [Related]
9. From targeted therapy to a novel way: Immunogenic cell death in lung cancer.
Xu J; Xiong Y; Xu Z; Xing H; Zhou L; Zhang X
Front Med (Lausanne); 2022; 9():1102550. PubMed ID: 36619616
[TBL] [Abstract][Full Text] [Related]
10. Tumor Microenvironment-Activatable Prodrug Vesicles for Nanoenabled Cancer Chemoimmunotherapy Combining Immunogenic Cell Death Induction and CD47 Blockade.
Zhou F; Feng B; Yu H; Wang D; Wang T; Ma Y; Wang S; Li Y
Adv Mater; 2019 Apr; 31(14):e1805888. PubMed ID: 30762908
[TBL] [Abstract][Full Text] [Related]
11. Targeting of focal adhesion kinase enhances the immunogenic cell death of PEGylated liposome doxorubicin to optimize therapeutic responses of immune checkpoint blockade.
Zhang B; Li N; Gao J; Zhao Y; Jiang J; Xie S; Zhang C; Zhang Q; Liu L; Wang Z; Ji D; Wu L; Ren R
J Exp Clin Cancer Res; 2024 Feb; 43(1):51. PubMed ID: 38373953
[TBL] [Abstract][Full Text] [Related]
12. Immunogenic cancer cell death selectively induced by near infrared photoimmunotherapy initiates host tumor immunity.
Ogawa M; Tomita Y; Nakamura Y; Lee MJ; Lee S; Tomita S; Nagaya T; Sato K; Yamauchi T; Iwai H; Kumar A; Haystead T; Shroff H; Choyke PL; Trepel JB; Kobayashi H
Oncotarget; 2017 Feb; 8(6):10425-10436. PubMed ID: 28060726
[TBL] [Abstract][Full Text] [Related]
13. A Cascade-Targeted Enzyme-Instructed Peptide Self-Assembly Strategy for Cancer Immunotherapy through Boosting Immunogenic Cell Death.
Xie L; Ding Y; Zhang X; Zhang Z; Zeng S; Wang L; Yang Z; Liu Q; Hu ZW
Small Methods; 2023 May; 7(5):e2201416. PubMed ID: 36965100
[TBL] [Abstract][Full Text] [Related]
14.
Qi JL; He JR; Jin SM; Yang X; Bai HM; Liu CB; Ma YB
Front Oncol; 2020; 10():610651. PubMed ID: 33643911
[TBL] [Abstract][Full Text] [Related]
15. Tumor Microenvironment-Triggered Aggregated Magnetic Nanoparticles for Reinforced Image-Guided Immunogenic Chemotherapy.
Chen Q; Liu L; Lu Y; Chen X; Zhang Y; Zhou W; Guo Q; Li C; Zhang Y; Zhang Y; Liang D; Sun T; Jiang C
Adv Sci (Weinh); 2019 Mar; 6(6):1802134. PubMed ID: 30937276
[TBL] [Abstract][Full Text] [Related]
16. Bioactive Peptide Nanodrugs Based on Supramolecular Assembly for Boosting Immunogenic Cell Death-Induced Cancer Immunotherapy.
Liu Y; Chang R; Xing R; Yan X
Small Methods; 2023 May; 7(5):e2201708. PubMed ID: 36720041
[TBL] [Abstract][Full Text] [Related]
17. Natural Compounds of Marine Origin as Inducers of Immunogenic Cell Death (ICD): Potential Role for Cancer Interception and Therapy.
Sansone C; Bruno A; Piscitelli C; Baci D; Fontana A; Brunet C; Noonan DM; Albini A
Cells; 2021 Jan; 10(2):. PubMed ID: 33504012
[TBL] [Abstract][Full Text] [Related]
18. Cryoimmunotherapy with local co-administration of ex vivo generated dendritic cells and CpG-ODN immune adjuvant, elicits a specific antitumor immunity.
Alteber Z; Azulay M; Cafri G; Vadai E; Tzehoval E; Eisenbach L
Cancer Immunol Immunother; 2014 Apr; 63(4):369-80. PubMed ID: 24452202
[TBL] [Abstract][Full Text] [Related]
19. Chemoimmunotherapy with doxorubicin and caffeine combination enhanced ICD induction and T-cell infiltration in B16F10 melanoma tumors.
Yerragopu AK; Vellapandian C
J Biochem Mol Toxicol; 2023 May; 37(5):e23327. PubMed ID: 36807623
[TBL] [Abstract][Full Text] [Related]
20. Inducing immunogenic cell death in immuno-oncological therapies.
Ti D; Yan X; Wei J; Wu Z; Wang Y; Han W
Chin J Cancer Res; 2022 Feb; 34(1):1-10. PubMed ID: 35355932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
